New drug could be ‘gamechanger’ for chronic cough sufferers

Lung doctor says Gefapixant could be first new treatment for condition to be approved in UK for more than 50 years

A new drug to treat chronic coughs could be a gamechanger" treatment for the thousands of Britons who cough uncontrollably, many times a day.

Prof Surinder Birring, a leading lung doctor, has led a global trial that found Gefapixant reduces a person's coughing by up to 60% and brings some relief to 70% of those who take it.